The winning research projects use data from the unique tissue banks and databases of Israeli health institutions, while protecting patient privacy, according to the announcement.
In May of last year, 16 projects were selected for NIS 60 million ($ 17 million) in grants, and the previous year 14 teams were chosen for the first cohort, also with a budget of NIS 60 million.
The next call for proposals will be published in the coming months for the fourth and final cycle, according to the statement.
Among the 11 research studies selected, of the 99 presented, is a team of biologists, neurologists and pharmacologists from the Technion-Israel Institute of Technology, the Weizmann Institute of Science, the Tel Aviv University and the Sourasky-Ichilov Medical Center in Tel Aviv. who will receive NIS 3.6 million ($ 1.12 million) for a program to discover precision biomarkers for amyotrophic lateral sclerosis (ALS, also called Lou Gehrig’s disease).
A team from Weizmann Institute of Sciences and the Rabin (Beilinson) Medical Center in Petah Tikva will study the use of AI and “super resolution” algorithms to develop personalized diagnosis and treatment of breast cancer and Crohn’s disease, also with a grant of 3.6 million NIS ($ 1.12 million) .
A group of scientists from Hadassah Medical Center in Jerusalem, the Hebrew University of Jerusalem and the Instituto Weizmann will use high-dimensional imaging technology to study tumor-immune microenvironments in dozens of melanoma patients with the goal of developing predictive biomarkers to guide patient-specific therapy selections. His grant is NIS 2.8 million ($ 870,000).
Another team from Shaare Zedek Medical Center and the Hebrew University of Jerusalem will leverage an integrated computational and functional framework to identify genes and therapies in rare inherited diseases, with a grant of 2.2 million ($ 680,000).
The Israel Precision Medicine Association believes that collaborations between researchers at universities and healthcare institutions “significantly enhance research capabilities in the field in Israel, help accelerate the pace of discovery and the potential to implement new therapeutic approaches, and position Israel at the forefront of global research in precision medicine ”.
Reproduction authorized with the following mention: © EnlaceJudío